VICTORY CAPITAL MANAGEMENT INC

Position in ROIV — Roivant Sciences Ltd.

CIK 1040188 San Antonio, TX

Position in ROIV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$6,224,499

+$1,473,949 QoQ

Shares Held

175,883

+2.6% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#129

of 494 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. ROIV ranks #33 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,224,499	175,883	+2.6%	Shares	Sole	2026-08-07
2026-03-31	$4,750,550	171,500	-34.5%	Shares	Sole	2026-05-15
2025-12-31	$5,682,882	261,884	+1537.0%	Shares	Sole	2026-02-13
2025-09-30	$242,049	15,998	-31.4%	Shares	Sole	2025-11-12
2025-06-30	$262,692	23,309	-15.2%	Shares	Sole	2025-08-13
2025-03-31	$277,414	27,494	0.0%	Shares	Sole	2025-05-02
2024-12-31	$325,254	27,494	+6.1%	Shares	Sole	2025-02-06
2024-09-30	$298,955	25,906	-3.7%	Shares	Sole	2024-11-05
2024-06-30	$284,216	26,889	-78.0%	Shares	Sole	2024-08-05
2024-03-31	$1,286,196	122,030	+65.3%	Shares	Sole	2024-05-03
2023-12-31	$829,032	73,823	-91.4%	Shares	Sole	2024-02-05
2023-09-30	$10,066,874	861,890	-27.6%	Shares	Sole	2023-11-06
2023-06-30	$11,996,016	1,190,081	—	Shares	Other	2023-07-27
No filing history on record for this holder in this stock.